Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays

Abstract

Our previous studies have characterized Dexamethasone (Dex)-induced apoptotic signaling pathways in multiple myeloma (MM) cells; however, related transcriptional events are not fully defined. In the present study, gene expression profiles of Dex-treated MM cells were determined using oligonucleotide arrays. Dex triggers early transient induction of many genes involved in cell defense/repair-machinery. This is followed by induction of genes known to mediate cell death and repression of growth/survival-related genes. The molecular and genetic alterations associated with Dex resistance in MM cells are also unknown. We compared the gene expression profiles of Dex-sensitive and Dex-resistant MM cells and identified a number of genes which may confer Dex-resistance. Finally, gene profiling of freshly isolated MM patient cells validates our in vitro MM cell line data, confirming an in vivo relevance of these studies. Collectively, these findings provide insights into the basic mechanisms of Dex activity against MM, as well as mechanisms of Dex-resistance in MM cells. These studies may therefore allow improved therapeutic uses of Dex, based upon targeting genes that regulate MM cell growth and survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Alexanian R, Dimopoulos MA, Delasalle K, Barlogie B . 1992 Blood 80: 887–890

  • Anderson KC, Jones RM, Morimoto C, Leavitt P, Barut BA . 1989 Blood 73: 1915–1924

  • Anderson KC, Lust JL . 1999 Semin. Hematol. 36: 14–20

  • Anderson KC . 2001 Semin. Hematol. 38: 286–294

  • Barut B, Chauhan D, Uchiyama H, Anderson KC . 1993 J. Clin. Invest. 92: 2346–2352

  • Bataille R, Barlogie B, Lu ZY, Rossi JF, Lavabre-Bertrand T, Beck T, Wijdenes J, Brochier J, Klein B . 1995 Blood 86: 685–691

  • Barkett M, Gilmore TD . 1999 Oncogene 18: 6910–6924

  • Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, Merville MP . 2000 Biochem. Pharmacol. 60: 1085–1089

  • Bajpai UD, Zhang K, Teutsch M, Sen R, Wortis HH . 2000 J. Exp. Med. 191: 1735–1744

  • Chaudhry A, Oberg K, Gobl A, Heldin CH, Funa K . 1994 Antican. Res. 14: 2085–2091

  • Chauhan D, Anderson KC . 2001 Apoptosis 6: 47–55

  • Chauhan D, Hideshima T, Pandey P, Treon SP, Teoh G, Rosen S, Krett N, Husson H, Avraham S, Kharbanda S, Anderson KC . 1999 Oncogene 18: 6733–6740

  • Chauhan D, Kharbanda SM, Rubin E, Barut BA, Mohrbacher A, Kufe DW, Anderson KC . 1993 Blood 81: 1540–1548

  • Chauhan D, Kharbanda SM, Uchiyama H, Sukhatme VP, Kufe DW, Anderson KC . 1994 Can. Res. 54: 2234–2239

  • Chauhan D, Pandey P, Ogata A, Teoh G, Krett N, Halgren R, Rosen S, Kufe D, Kharbanda S, Anderson KC . 1997a J. Biol. Chem. 272: 29995–29997

  • Chauhan D, Pandey P, Ogata A, Teoh G, Treon S, Urashima M, Kharbanda S, Anderson KC . 1997b Oncogene 15: 837–843

  • Chauhan D, Pandey P, Hideshima TH, Treon S, Raje N, Davies FE, Shima Y, Tai YT, Rosen S, Avraham S, Kharbanda S, Anderson KC . 2000 J. Biol. Chem. 275: 27845–27850

  • Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto K, Libermann TA, Anderson KC . 1996 Blood 87: 1104–1112

  • Combadiere C, Salzwedel K, Smith ED, Tiffany HL, Berger EA, Murphy PM . 1998 J. Biol. Chem. 273: 23799–23804

  • Der SD, Zhou A, Williams BR, Silverman RH . 1998 Proc. Natl. Acad. Sci. USA 95: 15623–15628

  • Desai SD, Mao Y, Sun M, Li TK, Wu J, Liu LF . 2000 Ann. NY Acad. Sci. 922: 306–308

  • Dell'Angelica EC, Ohno H, Ooi CE, Rabinovich E, Roche KW, Bonifacino JS . 1997 EMBO J. 16: 917–928

  • Eisen MB, Spellman PT, Brown PO, Botstein D . 1998 Proc. Natl. Acad. Sci. USA 95: 14863–14868

  • Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS . 1999 Blood 93: 3044–3052

  • Fischer CP, Bode BP, Takahashi K, Tanabe KK, Souba WW . 1996 Ann. Surg. 223: 610–618 Discussion 618–619

  • Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A . 2001 J. Clin. Invest. 107: 1173–1181

  • Goldman-Leikin RE, Salwen HR, Herst CV, Variakojis D, Bian ML, Le Beau MM, Selvanayagan P, Marder R, Anderson R, Weitzman S . 1989 J. Lab. Clin. Med. 113: 335–345

  • Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo AP, Chauffert B, Mehlen P . 1997 Cancer Res. 57: 2661–2667

  • Garrido C, Fromentin A, Bonnotte B, Favre N, Moutet M, Arrigo AP, Mehlen P, Solary E . 1998 Cancer Res. 58: 5495–5499

  • Golub TR, Slonim D, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES . 1999 Science 286: 531–537

  • Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E . 1999 FASEB J. 13: 2061–2070

  • Hardin J, Macleod S, Grigorieva I, Chang R, Barlogie B, Xiao X, Epstein J . 1994 Blood 84: 3063–3070

  • Hideshima T, Chauhan D, Schlossman R, Richardson P, Anderson KC . 2001a Oncogene 20: 4519–4527

  • Hideshima T, Nakamura N, Chauhan D, Anderson KC . 2001b Oncogene 20: 5991–6000

  • Hideshima T, Richardson P, Chauhan D, Palaomabella V, Elliott PJ, Adams J, Anderson KC . 2001c Con. Res. 61: 3071–3076

  • Juge-Morineau N, Francois S, Puthier D, Godard A, Bataille R, Amiot M . 1995 Br. J. Haematol. 90: 707–710

  • Jaattela M . 1999 Ann. Med. 31: 261–271

  • Jaattela M, Wissing D, Kokholm K, Kallunki T, Egeblad M . 1998 EMBO J. 17: 6124–6134

  • Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW . 2001 J. Biol. Chem. 276: 11199–11203

  • Karin M, Ben-Neriah Y . 2000 Annu. Rev. Immunol. 18: 621–663

  • Klein B, Zhang XG, Jourden M, Content M, Houssiau F, Aarden L, Piechaczyk M, Bataille R . 1989 Blood 73: 517–526

  • Kohler HB, Huchzermeyer B, Martin M, De Bruin A, Meier B, Nolte I . 2001 Vet. Dermatol. 12: 129–137

  • Krett NL, Zell JL, Halgren RG, Pillay S, Traynor AE, Rosen ST . 1997 Clin. Can. Res. 3: 1781–1787

  • Kudoh K, Manasi R, Ravatin R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV . 2001 Can. Res. 60: 4161–4166

  • Lichtenstein A, Tu Y, Fady C, Vescio R, Berenson J . 1995 Cell Immunol. 162: 248–255

  • Levy Y, Labaume S, Colombel M, Brouet JC . 1996 Clin. Exp. Immunol. 104: 167–172

  • Li C, Wong WH . 2001 Proc. Natl. Acad. Sci. USA 98: 31–36

  • Matsuda S, Rouault J, Magaud J, Berthet C . 2001 FEBS Lett. 497: 67–72

  • Moalli PA, Pillay S, Weiner D, Leikin R, Rosen ST . 1992 Blood 79: 213–222

  • Moalli PA, Pillay S, Krett NL, Rosen ST . 1993 Cancer Res. 53: 3877–3879

  • Mehlen P, Schulze-Osthoff K, Arrigo AP . 1996 J. Biol. Chem. 271: 16510–16514

  • Mori S, Murakami-Mori K, Bonavida B . 1998 Antican. Res. 18: 4403–4408

  • Ogata A, Chauhan D, Teoh G, Treon SP, Urashima M, Schlossman RL, Anderson KC . 1997 J. Immunology 159: 2212–2221

  • Pahl HL . 1999 Oncogene 18: 6853–6866

  • Petro JB, Khan WN . 2001 J. Biol. Chem. 276: 1715–1719

  • Podar K, Tai TY, Davies FE, Lentzsch S, Sattler M, Hideshima T, Lin BK, Gupta D, Chauhan D, Mitsiades C, Raje N, Richardson P, Anderson K . 2001 Blood 98: 428–435

  • Rowland TL, McHugh SM, Deighton J, Ewan PW, Dearman RJ, Kimber I . 2001 Int. Immunopharmacol. 1: 49–61

  • Salmon SE . 1984 Cancer Treat. Rep. 68: 117–125

  • Smith MR, Xie T, Joshi I, Schilder RJ . 1998 Br. J. Haematol. 102: 1090–1097

  • Spataro V, Norbury C, Harris AL . 1998 Br. J. Cancer 77: 448–455

  • Tassone P, Forciniti S, Galea E, Savino R, Turco MC, Iacopino P, Tagliaferri P, Morrone G, Ciliberto G, Venuta S . 2000 Cell Death Differ. 7: 327–328

  • Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC . 1993 Blood 82: 3712–3720

  • Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales MB, Dedera DA, Schlossman RL, Anderson KC . 1996 Blood 87: 1928–1938

  • Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE . 2001 Am. J. Pathol. 159: 1521–1530

  • Wu C, Ghosh S . 1999 J. Biol. Chem. 274: 29591–29594

  • Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL, Colburn NH . 2001 Oncogene 20: 669–676

  • Zimmermann J, Erdmann D, Lalande I, Grossenbacher R, Noorani M, Furst P . 2000 Oncogene 19: 2913–2920

Download references

Acknowledgements

This investigation was supported by NIH CA 78373 awarded by the National Cancer Institute, Multiple Myeloma Research Foundation Senior Research Scientist Awards (D Chauhan, T Hideshima), and a Doris Duke Distinguished Clinical Research Scientist Award (KC Anderson).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenneth C Anderson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chauhan, D., Auclair, D., Robinson, E. et al. Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays. Oncogene 21, 1346–1358 (2002). https://doi.org/10.1038/sj.onc.1205205

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205205

Keywords

This article is cited by

Search

Quick links